MYCN and neuroblastoma: Most genes in ribosome signaling pathway were up-regulated in MYCN amplified neuroblastoma patients, as demonstrated the RPS19 expression levels in TARGET, GSE19274, GSE49710, GSE73517 and GSE85047 datasets (Fig. 6b).